Hongyang Deng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hongyang Deng has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Xiaodong Xu
Department of General Surgery, Hepatic-Biliary-Pancreatic Institute, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
3 shared publications - Fahong Wu
Hepatic-Biliary-Pancreatic Institute, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China
1 shared publication - Feng-Xian Wei
Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China
1 shared publication - Jiaxing Zhang
Key Laboratory of the Digestive System Tumors of Gansu Province, Lanzhou University Second Hospital, Lanzhou 730030, China
1 shared publication - Wei Han
Hepatic-Biliary-Pancreatic Institute, Department of General Surgery, Lanzhou University Second Hospital, Lanzhou 730030, China
1 shared publication - Yongfang Li
Department of Liver Disease, The Second Hospital & Clinical Medical School, Lanzhou University, Lanzhou, China
1 shared publication
Latest Publications
- Open Access
- 30 July 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-24
The complex role and molecular mechanism of family with sequence similarity genes in cancer: a comprehensive review
The family with sequence similarity (FAM) is a family of genes with unknown functions and similar sequences. However, recent studies have reported that many FAM members play important roles in the onset and progression of cancer. Specifically, the expression of this type of gene is abnormal in tissues and cells of different types of cancer and is related to the prognosis of cancer patients. In addition, their expression regulates the proliferation, migration, invasion, epithelial-mesenchymal transition (EMT), and drug resistance of different types of cancer cells. Some members even show dual and contradictory effects in tumor-promoting or suppressing cancer. In this review, we summarized the role of FAM members in various solid tumors and sorted out the regulatory mechanism of FAM involved in tumor signal transduction, confirming their role as an important node in tumor signal transduction. Their potential as tumor markers and therapeutic targets was highlighted, offering new insights for cancer research.
- 30 July 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-24
Open AccessThe complex role and molecular mechanism of family with sequence similarity genes in cancer: a comprehensive review
The family with sequence similarity (FAM) is a family of genes with unknown functions and similar sequences. However, recent studies have reported that many FAM members play important roles in the onset and progression of cancer. Specifically, the expression of this type of gene is abnormal in tissues and cells of different types of cancer and is related to the prognosis of cancer patients. In addition, their expression regulates the proliferation, migration, invasion, epithelial-mesenchymal transition (EMT), and drug resistance of different types of cancer cells. Some members even show dual and contradictory effects in tumor-promoting or suppressing cancer. In this review, we summarized the role of FAM members in various solid tumors and sorted out the regulatory mechanism of FAM involved in tumor signal transduction, confirming their role as an important node in tumor signal transduction. Their potential as tumor markers and therapeutic targets was highlighted, offering new insights for cancer research.
- Open Access
- 1 December 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (12) , rjae772
An improvement of pancreaticojejunostomy: double-row and six-suture method pancreaticojejunostomy for pancreaticoduodenectomy
With the rapid development of pancreaticoduodenectomy (PD) surgery, the incidence of postoperative pancreatic fistula (POPF) and surgical complications has been greatly reduced. The occurrence of POPF is closely related to the quality of the pancreatic reconstruction. Pancreaticojejunostomy (PJ) remains a significant technical challenge, and no PJ has yet been widely recognized. From January 2021 to December 2023, 72 patients underwent PD with double-row and six-suture PJ. The clinical characteristics and postoperative outcomes of these patients were analysed. The median operation time was 240 min (180–540 min). The median intraoperative blood loss was 200 ml (50–600 mL). The postoperative hospital stay was 11 days (8–27 days). Eleven patients (15.3%) had a biochemical fistula and five patients (6.9%) had a grade B POPF. No patient had a grade C POPF or died within 90 days after surgery. Double-row and six-suture PJ is a safe and acceptable PJ.
- 1 December 2024
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2024 (12) , rjae772
Open AccessAn improvement of pancreaticojejunostomy: double-row and six-suture method pancreaticojejunostomy for pancreaticoduodenectomy
With the rapid development of pancreaticoduodenectomy (PD) surgery, the incidence of postoperative pancreatic fistula (POPF) and surgical complications has been greatly reduced. The occurrence of POPF is closely related to the quality of the pancreatic reconstruction. Pancreaticojejunostomy (PJ) remains a significant technical challenge, and no PJ has yet been widely recognized. From January 2021 to December 2023, 72 patients underwent PD with double-row and six-suture PJ. The clinical characteristics and postoperative outcomes of these patients were analysed. The median operation time was 240 min (180–540 min). The median intraoperative blood loss was 200 ml (50–600 mL). The postoperative hospital stay was 11 days (8–27 days). Eleven patients (15.3%) had a biochemical fistula and five patients (6.9%) had a grade B POPF. No patient had a grade C POPF or died within 90 days after surgery. Double-row and six-suture PJ is a safe and acceptable PJ.
- Open Access
Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect
The lymphatic system is a channel for fluid transport and cell migration, but it has always been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has long been recognized as a major molecular driver of lymphangiogenesis. However, many studies have shown that the neural network of lymphatic signaling is complex. Lymphatic vessels have been found to play an essential role in the immune regulation of tumor metastasis and cardiac repair. This review describes the effects of lipid metabolism, extracellular vesicles, and flow shear forces on lymphangiogenesis. Moreover, the pro-tumor immune tolerance function of lymphatic vessels is discussed, and the tasks of meningeal lymphatic vessels and cardiac lymphatic vessels in diseases are further discussed. Finally, the value of conversion therapy targeting the lymphatic system is introduced from the perspective of immunotherapy and pro-lymphatic biomaterials for lymphangiogenesis.
Open AccessCurrent Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect
The lymphatic system is a channel for fluid transport and cell migration, but it has always been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has long been recognized as a major molecular driver of lymphangiogenesis. However, many studies have shown that the neural network of lymphatic signaling is complex. Lymphatic vessels have been found to play an essential role in the immune regulation of tumor metastasis and cardiac repair. This review describes the effects of lipid metabolism, extracellular vesicles, and flow shear forces on lymphangiogenesis. Moreover, the pro-tumor immune tolerance function of lymphatic vessels is discussed, and the tasks of meningeal lymphatic vessels and cardiac lymphatic vessels in diseases are further discussed. Finally, the value of conversion therapy targeting the lymphatic system is introduced from the perspective of immunotherapy and pro-lymphatic biomaterials for lymphangiogenesis.